Araqure Pharmaceuticals Private Limited

Araqure Pharmaceuticals Private Limited - chemicals in Delhi, India. Directors, charges & compliance details.
CIN U24290DL2021PTC387252 Incorporated 27 September 2021 ROC Delhi HQ Delhi, India
Active Private Limited Company chemicals DPIIT Startup MSME · Micro
Revenue · FY 2024
₹1.27 Cr
▲ 379% YoY
Net profit · FY 2024
₹3.97 Lakh
Net margin 3.1%
EBITDA · FY 2024
₹7.03 Lakh
EBITDA margin 5.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Araqure Pharmaceuticals Private Limited

Data last updated:

Araqure Pharmaceuticals Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 27 September 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC387252.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Piyush Malik and Ritu Malik.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 115 First Floor Plot No.H – 6 Aggarwal Tower Netaji Subhash Place, Delhi, India – 110034.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.27 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.97 Lakh (net margin 3.1%) and EBITDA of ₹7.03 Lakh (EBITDA margin 5.5%).

Araqure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0036896).

Company details

CIN U24290DL2021PTC387252
Registration Number 387252
Incorporation Date 27 September 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0036896

Recognitions & Rankings of Araqure Pharmaceuticals

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-06-0036896

Contact details

Araqure Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.

  • Registered Address
    Office No. 115 First Floor Plot No.H – 6 Aggarwal Tower Netaji Subhash Place, Delhi, India – 110034
  • Industry
    Chemicals, Other Chemical Product, Manufacturing
Comprehensive company report
Araqure Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Araqure Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Araqure Pharmaceuticals Private Limited, buy the company report.

Financials of Araqure Pharmaceuticals Private Limited

FY 2025 filings available

Araqure Pharmaceuticals Private Limited reported revenue of ₹1.27 Cr (up 379% YoY) for FY 2024.

Revenue · FY 2024
₹1.27 Cr ▲ 379%
Net profit · FY 2024
₹3.97 Lakh margin 3.1%
EBITDA · FY 2024
₹7.03 Lakh margin 5.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 379%
EBITDA CAGR growth
1 year
▲ 130%

Revenue rose 379% in the latest year. EBITDA rose 130% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.03 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.97 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin5.5%
Net Profit Margin3.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Araqure Pharmaceuticals Private Limited, buy the company report.

Board of directors of Araqure Pharmaceuticals Private Limited

Araqure Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Piyush MalikDirector27 Sep 20215 Years 1 MonthsCurrent
Ritu MalikDirector27 Sep 20215 Years 1 MonthsCurrent

Peer comparison

Araqure Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Ayucare Pharmaceuticals Pvt Ltd₹1.29 Cr (FY 2024)0.0%Ahmedabad, Gujarat, India
Safron Pharmaceuticals Private Limited₹1.28 Cr (FY 2024)-41.0%Mumbai, Maharashtra, India
Araqure Pharmaceuticals Private Limitedthis company₹1.27 Cr (FY 2024)₹3.97 Lakh3.1%379.0%Delhi, India
Asterin Pharmaceuticals Private Limited₹1.26 Cr (FY 2025)9.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Araqure Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Araqure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Araqure Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Araqure Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Piyush Malik was appointed as Director on 27 Sep 2021.

AGM
Araqure Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Araqure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Piyush Malik was appointed as Director.
Appointed
Ritu Malik was appointed as Director.
Incorporation
27 Sep 2021
Araqure Pharmaceuticals Private Limited was registered on 27 Sep 2021 with Roc Delhi Ii & aged 5 years 1 month as per MCA records.

Frequently asked questions

Araqure Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 27 September 2021 (5+ years old) and is registered under CIN U24290DL2021PTC387252.

Araqure Pharmaceuticals has 2 current directors:

The latest financial statements of Araqure Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Araqure Pharmaceuticals is U24290DL2021PTC387252. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Araqure Pharmaceuticals was incorporated on 27 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Araqure Pharmaceuticals by revenue are Ayucare Pharmaceuticals Pvt Ltd, Safron Pharmaceuticals Private Limited, Asterin Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Piyush Malik was appointed as Director on 27 Sep 2021. Ritu Malik was appointed as Director on 27 Sep 2021.

Yes, Araqure Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Araqure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0036896).

The registered office of Araqure Pharmaceuticals is at Office No. 115 First Floor Plot No.H – 6 Aggarwal Tower Netaji Subhash Place, Delhi, India – 110034.

Araqure Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.